| Nov 20 |
Ionis Pharmaceuticals, Inc. (IONS): Among the Best Genomics Stocks to Buy Right Now
|
| Nov 18 |
Here's Why Ionis Pharmaceuticals (IONS) is Poised for a Turnaround After Losing -13.46% in 4 Weeks
|
| Nov 8 |
Ionis Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations
|
| Nov 7 |
Ionis' Q3 Earnings and Revenues Beat Estimates, New Launches in Focus
|
| Nov 7 |
A Glimpse Into The Expert Outlook On Ionis Pharmaceuticals Through 5 Analysts
|
| Nov 7 |
Company News for Nov 7, 2024
|
| Nov 7 |
Ionis announces design for Phase III trial of Angelman syndrome therapy
|
| Nov 7 |
Q3 2024 Ionis Pharmaceuticals Inc Earnings Call
|
| Nov 7 |
Ionis Pharmaceuticals Inc (IONS) Q3 2024 Earnings Call Highlights: Navigating Revenue ...
|
| Nov 6 |
Ionis Pharmaceuticals, Inc. (IONS) Q3 2024 Earnings Call Transcript
|
